Autonomix Medical Secures New U.S. Patent for Neuromodulation Technologies

Autonomix Medical, Inc. has announced the issuance of U.S. Patent No. 12,471,776, which strengthens its intellectual property portfolio for advanced autonomic nervous system assessment technologies. The patent covers systems and methods for monitoring physiological signals and supports improvements in patient selection and treatment precision for nerve-targeted therapies. The company aims to transform diagnosis and treatment of diseases involving the peripheral nervous system.